from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0486/mshA

LFCtreatmentdescriptionclass of inhibitor

-0.885

Amikacinug/mL Amikacintranslation

-0.789

Cap5-10ug/mL Capreomycintranslation

-0.761

Rox10-50 ug/mL Roxithromycintranslation

0.865

SM2-5 ug/mL Streptomycintranslation

-1.423

Tet5-10 ug/mL Tetracyclinetranslation

-0.460

Rif0.2-5ug/mL Rifampicintranscription

-0.598

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.766

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.946

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.281

CPZ10-50 ug/mL Chlorpromazinerespiration

0.505

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.122

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.725

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.948

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.063

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.274

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.152

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.403

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.234

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.057

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.186

KCN5-20 ug/mL Potassium cyaniderespiration

0.612

NaN30.2-2 mM Sodium aziderespiration

-0.141

Nigericin50 uM Nigericinrespiration

0.808

TRC10-150 ug/mL Triclosanrespiration

0.520

TRZ10-25 ug/mL Thioridazinerespiration

0.248

Valinomycin0.5-10 uM Valinomycinrespiration

-0.918

ZnSO42 mM ZnSO4respiration

0.173

menadione6-10 ug/mL Menadionerespiration

-0.159

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.479

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.202

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.566

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.310

NRP_1Non-replicating persistence stage 1dosRassociated

-0.452

Amp0.2mg/mL AmpicillincellWall

-0.208

Cephalexin20-100 ug/mL CephalexincellWall

-0.695

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.878

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.059

EMB10-20 ug/mL EthambutolcellWall

-0.838

Eta12-40 ug/mL EthionamidecellWall

-0.638

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.739

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.464

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.709

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.606

BZA0.12 mg/mL BenzamidearomaticAmides

0.460

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.023

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.242

H2O24 mM hydrogen peroxideDNAdamaging

-0.566

Levo10 ug/mL LevofloxacinDNAdamaging

-0.127

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.450

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.992

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.002

UVUV-irradiationDNAdamaging

0.889

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.150

Antimycin12.5-50 ug/mL Antimycin A?

-0.655

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.003

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.417

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.457

PA8240.2-2 ug/mL PA-824?

1.803

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.680

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.551

Verapamil50 uM Verapamil?

-0.284

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.672

methoxatin10-20 ug/mL Methoxatin?